Skip to main content
IBSRELA 53.2 mg/1 tablet by Ardelyx, Inc.
IBSRELA, 53.2 mg/1, tablet Drug class: Sodium-Hydrogen Exchanger 3 Inhibitor. Available on prescription only. Listed by Ardelyx, Inc..
Prescription only

IBSRELA

tenapanor hydrochloride

Listed by Ardelyx, Inc.

Strength
53.2 mg/1
Form
Tablet
Route
Oral
Class
Sodium-Hydrogen Exchanger 3 Inhibitor

What it contains

  • Tenapanor Hydrochloride 53.2 mg/1

FDA record

Dosage form Tablet
Route Oral
Drug class Sodium-Hydrogen Exchanger 3 Inhibitor
Approval route NDA — original brand approval
NDC code 73154-050
FDA application NDA211801
RxNorm concept 2199679
Package sizes listed 2
Marketed since September 2019

Other products containing Tenapanor

See all

Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.

XPHOZAH 10 mg

Tenapanor

Strength
10 mg/1
Form
Tablet, Film Coated
Class
Sodium-Hydrogen Exchanger 3 Inhibitor
Rx only

Ardelyx, Inc.

Not stocked by us — reference only

XPHOZAH 20 mg

Tenapanor

Strength
20 mg/1
Form
Tablet, Film Coated
Class
Sodium-Hydrogen Exchanger 3 Inhibitor
Rx only

Ardelyx, Inc.

Not stocked by us — reference only

XPHOZAH 30 mg

Tenapanor

Strength
30 mg/1
Form
Tablet, Film Coated
Class
Sodium-Hydrogen Exchanger 3 Inhibitor
Rx only

Ardelyx, Inc.

Not stocked by us — reference only

Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.